What's Next for The Ensign Group, Inc. Shareholders After 8.2% Stock Drop? Glancy Prongay Wolke & Rotter LLP Explains Securities Fraud Class Action Lead Plaintiff Deadline

Complaint alleges The Ensign Group, Inc. misled investors between February 10, 2022 and June 18, 2026; investors may seek lead plaintiff role by December 7, 2026

LOS ANGELES, Oct. 19, 2026 /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP ("Glancy") announced today that the class action lawsuit covers investors who bought The Ensign Group, Inc. ("Ensign Group" or the "Company") (NASDAQ: ENSG) securities between February 10, 2022 and June 18, 2026. The Ensign Group, Inc. case, Perusek v. The Ensign Group, Inc. et al., was filed on October 8, 2026 in the U.S. District Court Central District of California (Case No. 8:26-cv-02963).

Investors who suffered losses on The Ensign Group, Inc. investments can submit their The Ensign Group, Inc. loss information here before the December 7, 2026 lead plaintiff deadline.

Key dates in the Ensign Group, Inc. case

• Class period: February 10, 2022 to June 18, 2026
• Complaint filed: October 8, 2026
• Lead plaintiff deadline: December 7, 2026

What happened?

On June 8, 2026, investment media group Hunterbrook Media published a report entitled "Ensign: The Nursing Home Empire Built on Fatal Neglect," alleging that Ensign's business model relies on delivering inadequate care to patients while gaming quality data, and that the Company padded its profit margin by understaffing facilities while routing Medicare and Medicaid payments to affiliate entities owned or controlled by Ensign. Former employees in different states described systematic misrepresentations.

On this news, Ensign's stock price fell $13.88, or 8.2%, to close at $156.42 per share on June 8, 2026, thereby injuring investors.

Then, on June 11, 2026, Muddy Waters Research published a report titled "Ensign: Deceiving the Government at Estimated ~20% of Facilities," alleging Ensign rents required nursing-home administrator licenses from off-site administrators who do not actually oversee its facilities to create the appearance of regulatory compliance.

On this news, Ensign's stock price fell as much as 6.6% during intraday trading on June 11, 2026, thereby injuring investors further; in total, over $500 million of Ensign's market capitalization was wiped out since June 7, 2026.

What is the Ensign Group, Inc. lawsuit about?

The Ensign Group, Inc. securities lawsuit alleges that, between February 10, 2022 and June 18, 2026, defendants made materially false and/or misleading statements and failed to disclose material adverse facts about The Ensign Group, Inc.'s business, operations, and prospects. Specifically, the complaint alleges defendants failed to disclose that: (1) Ensigns business model depends on the systematic and widespread neglect of elderly people who live in its facilities, including not giving residents enough food, medical attention, or even basic toiletries as well as failing to respond to residents in clear distress, which has resulted in resident deaths; (2) Ensign uses self-reporting measures as a way to cover up that it systematically neglects patients; (3) Ensign defrauds Medicaid and Medicare by taking federal funds to help patients who need high levels of care, and then neglecting those same patients as well as falsifying the number of hours that Certified Nursing Assistants spend with residents; (4) Ensign engages in an illegal scheme to rent the licenses of Administrators who are not generally present at, nor actually managing, its facilities; (5) Ensign materially understated the reputational and litigation exposure that comes with a dangerous, abhorrent, and illegal business model; and (6) as a result, defendants' positive statements about The Ensign Group, Inc.'s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

"The complaint filed against The Ensign Group, Inc. alleges that, among other things, the Company failed to disclose that Ensigns business model depends on the systematic and widespread neglect of elderly people who live in its facilities, including not giving residents enough food, medical attention, or even basic toiletries as well as failing to respond to residents in clear distress, which has resulted in resident deaths. For investors who bought during the class period, the December 7, 2026 deadline is the first major step in this case," said Charles H. Linehan, Partner at Glancy Prongay Wolke & Rotter LLP.

What's the next step?

Glancy Prongay Wolke & Rotter LLP is a leading national shareholder rights law firm, ready to assist The Ensign Group, Inc. investors in potentially pursuing claims to recover their losses.

If you wish to serve as lead plaintiff in the Ensign Group, Inc. class action, you must move the Court no later than December 7, 2026. To learn more about your rights, visit the Ensign Group, Inc. case page, email [email protected], or call 310-201-9150 (toll-free: 888-773-9224).

You may retain counsel of your choice. If you bought The Ensign Group, Inc. securities during the class period, you may take no action and remain an absent class member. No class has been certified yet in the Ensign Group, Inc. case.

Frequently Asked Questions

Who is eligible? Investors who purchased or otherwise acquired The Ensign Group, Inc. securities between February 10, 2022 and June 18, 2026 and suffered losses may be members of the proposed class in the Ensign Group, Inc. shareholder lawsuit. Any class member may ask the court to appoint them lead plaintiff by December 7, 2026.

What is a lead plaintiff? In the Ensign Group, Inc. class action, the lead plaintiff is the investor, or group of investors, that the court appoints to represent all class members and oversee the case. Under the Private Securities Litigation Reform Act, courts generally presume the movant with the largest financial interest is the most adequate lead plaintiff.

Do I have to be lead plaintiff to recover? No. A The Ensign Group, Inc. investor's ability to share in any future recovery does not depend on serving as lead plaintiff. The Ensign Group, Inc. investors may take no action and remain absent class members.

What is the deadline? Motions to serve as lead plaintiff in the Ensign Group, Inc. class action must be filed by December 7, 2026.

Does it cost anything to contact Glancy or participate in this action? Glancy represents The Ensign Group, Inc. investors on a contingency fee basis, which means investors pay no attorneys' fees unless there is a recovery. Any fees are subject to court approval and are paid from the recovery.

Can I choose my own lawyer? Yes. The Ensign Group, Inc. investors may retain counsel of their choice.

Why work with Glancy on the Ensign Group, Inc. lawsuit? Glancy Prongay Wolke & Rotter LLP is a premier law firm with decades of experience representing investors and consumers in securities litigation and other complex class action litigation. Contact Glancy about the Ensign Group, Inc. lawsuit. Prior results do not guarantee a similar outcome.

About Glancy Prongay Wolke & Rotter LLP

Glancy was named one of Law360's Securities Groups of the Year and ranked second in total investor recoveries by ISS Securities Class Action Services in 2025.

Glancy's successes have been widely covered by leading news and industry publications, including The Wall Street Journal, The Financial Times, Bloomberg Businessweek, Reuters, the Associated Press, Barron's, Investor's Business Daily, Forbes, and Money.

Prior results do not guarantee a similar outcome.

Related links

• The Ensign Group, Inc. case page, Glancy Prongay Wolke & Rotter LLP
• Complaint: Perusek v. The Ensign Group, Inc. et al., U.S. District Court Central District of California
• Muddy Waters Research report
• The Ensign Group, Inc. SEC filings index, EDGAR
• Glancy Prongay Wolke & Rotter LLP

Contact
Charles H. Linehan
Glancy Prongay Wolke & Rotter LLP
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Email: [email protected]
Telephone: 310-201-9150 | Toll-free: 888-773-9224
www.glancylaw.com

Follow Glancy on LinkedIn, X, or Facebook.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

SOURCE Glancy Prongay Wolke & Rotter LLP